| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |